Nevertheless, upregulation of CD80 and CD86 on tumor cells was observed after treatment with OV-OX40L/IL12 ex vivo or in vivo in our study, suggesting that including some costimulatory ligands is sufficient to jump-start a network of costimulatory signals. The gene discussed is CD80; the disease is neoplasm.